Results 13,321-13,340 of 21,090 for speaker:Alan Kelly
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I do not want to wrong him, as I think he has done a good job.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: On the labs, does any of the witnesses yet have a copy of the tenders that were put out a number of years ago, which were destroyed? I do not imply there was any wrongdoing in that regard but has anyone found any copies of the original tenders? Statistically, Dr. Scally found that the labs were clear as regards international norms. I accept that. However, what I do not understand is...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: In fairness to the witnesses, it must be said that the answers they are giving are pretty direct. It has been a failure. It should not have happened. The labs were not inspected when cases were settled. These cases were not just about non-disclosure but were about potential negligence and in that context, the labs should have been inspected. Let us be honest about that.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: My next question is for Mr. Ciarán Breen. In the context of the Taoiseach's comments that the women affected would not have to take the legal course and following the publication of Mr. Justice Meenan's report, how will the State Claims Agency ensure that women do not end up in court or, if they do end up in court, how will it help them if they decide not to be in the process outlined...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: It is the review of all of the slides of the women affected which is being conducted by the Royal College of Obstetricians and Gynaecologists.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Yes. My last question is also for the HSE. What is the intended date for the implementation of HPV testing as part of cervical check? This is a very important question and lots of people watching these proceedings want to know the answer. This is absolutely critical. We need a date. A few months ago we were told it would happen within six months. When will HPV testing begin? What is...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I accept that and to be honest I think the State Claims Agency is caught in a bind because of the commitments made by the Taoiseach.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: That would be great.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: When is it beginning?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I understand that but when will the actual work begin?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: It is expected to take six months.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: That is very welcome news. I would encourage the utilisation of the public system to the greatest extent possible.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I thank the witnesses for the clarity they have brought. It has been pretty good.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: I thank the committee very much for accommodating me. I am attending another committee at the same time, so I have been in and out. I have a few quick questions. With regard to disclosure, we know the Civil Liability (Amendment) Act 2017 is in place and that the patient safety Bill will come into place. Disclosure, including mandatory disclosure, is one of the biggest issues that arose...
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: What changes does that mean from a day-to-day point of view?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: What is the difference for the SCA post Scally, compared with the pre-Scally report position?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: In layman's terms, there cannot actually be any change.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: Has the HSE set up an office to deal with all of the implementation of open disclosure?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: The HSE will have to tick-tack with the SCA quite a bit.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Alan Kelly: How many times have the HSE and SCA met on this issue since the Scally report was published?